Cardiff Lexington Corp. reports third quarter revenue of $3.1 million

Reuters
Nov 14
<a href="https://laohu8.com/S/CDIX">Cardiff Lexington</a> Corp. reports third quarter revenue of $3.1 million

Cardiff Lexington Corp. reported third quarter 2025 financial results, with total revenue rising 125.6% to $3.1 million compared to the same period in 2024. Gross profit increased 437.8% to $1.9 million, and income from continuing operations grew 209.9% to $643,000. Non-GAAP adjusted EBITDA reached $1.9 million for the first nine months of 2025, up from $1.5 million in the same period of 2024. Cash totaled $232,000 and total assets increased 15.4% to $27.6 million as of September 30, 2025. The company noted continued organic growth, rising patient volumes, and stated that mergers and acquisitions remain a priority. A restatement was made to the 2024 cash flow classification, with no impact on balance sheets, statements of operations, or total cash flows.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardiff Lexington Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1102261) on November 14, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10